USD 3.16
(0.32%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 320.52 Million | 925.27 Million | 515.36 Million | 188.18 Million | 327.06 Million | 324.43 Million |
Net Income | 9.78 Million | 656.83 Million | 314.67 Million | -57.82 Million | -55.39 Million | 102.21 Million |
Depreciation & Amortization | 230.21 Million | 217.05 Million | 215.36 Million | 225.25 Million | 384.75 Million | 130.36 Million |
Deferred income taxes | 6.17 Million | 200.48 Million | 94.26 Million | -13.41 Million | -34.8 Million | 39.93 Million |
Stock-based compensation | -460.42 Million | -217.05 Million | 2.43 Million | 2.42 Million | 4.27 Million | 7.69 Million |
Change in working capital | 19.47 Million | -25.66 Million | -21.16 Million | 5.97 Million | -5.15 Million | 12.59 Million |
Other non-cash items | 515.31 Million | 93.62 Million | 127.58 Million | 25.76 Million | 33.38 Million | 31.63 Million |
Investing Cash Flow | -338.86 Million | -338.53 Million | -247.38 Million | -278.65 Million | -292.03 Million | -307.45 Million |
Investments in PPE | -308 Million | -364.62 Million | -230.47 Million | -289.67 Million | -296.34 Million | -303.28 Million |
Acquisitions | 87 Thousand | -2.34 Million | -283 Thousand | 12.88 Million | - | -3.9 Million |
Investment purchases | -1.24 Million | -1.95 Million | -1.25 Million | - | - | - |
Sales/Maturities of investments | - | - | 1.25 Million | - | - | - |
Other Investing Activities | -29.7 Million | 30.38 Million | -16.62 Million | -1.87 Million | 4.31 Million | -271 Thousand |
Financing Cash Flow | 18.31 Million | -586.72 Million | -267.98 Million | 90.46 Million | -35.01 Million | -16.97 Million |
Debt repayment | -238.41 Million | -2.45 Million | -2.44 Million | -2.29 Million | -2.17 Million | - |
Dividends payments | -213.34 Million | -76.95 Million | -13.54 Million | -18.62 Million | -35.61 Million | -34.27 Million |
Common Stock Repurchased | -11.46 Million | -145.47 Million | -33.16 Million | -9.73 Million | -73 Thousand | - |
Common Stock Issuance | 7.16 Million | 23 Million | 12.64 Million | -596 Thousand | 73 Thousand | - |
Other Financing Activities | 474.37 Million | -384.84 Million | -231.46 Million | 121.71 Million | 2.76 Million | 17.3 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 19.47 Million | -25.66 Million | -21.16 Million | 5.97 Million | -5.15 Million | - |
Cash at beginning of period | 74 Thousand | 63 Thousand | 60 Thousand | 70 Thousand | 53 Thousand | 48 Thousand |
Cash at end of period | 55 Thousand | 74 Thousand | 63 Thousand | 60 Thousand | 70 Thousand | 53 Thousand |
Capital Expenditure | -308 Million | -364.62 Million | -230.47 Million | -289.67 Million | -296.34 Million | -303.28 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -19 Thousand | 11 Thousand | 3000.00 | -10 Thousand | 17 Thousand | 5000.00 |
Free Cash Flow | 12.52 Million | 560.65 Million | 284.89 Million | -101.49 Million | 30.72 Million | 21.14 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 46.38 Million | -15.03 Million | 9.78 Million | -5.53 Million | 15.1 Million | 42.75 Million |
Depreciation & Amortization | 61.76 Million | 59.6 Million | 230.21 Million | 60.4 Million | 56.04 Million | 57.34 Million |
Deferred income taxes | 14.4 Million | -3.71 Million | 6.17 Million | -2.04 Million | 5.55 Million | 13.99 Million |
Stock-based compensation | 1.37 Million | - | -460.42 Million | -7.32 Million | 2.51 Million | 2.42 Million |
Change in working capital | -26.57 Million | 13.16 Million | 19.47 Million | 6.24 Million | -3.6 Million | -6.13 Million |
Other non-cash items | 51.02 Million | 130.44 Million | 515.31 Million | 140.74 Million | 50.77 Million | 11.74 Million |
Investing Cash Flow | -52.74 Million | -98.52 Million | -338.86 Million | -78.44 Million | -52.12 Million | -89.15 Million |
Investments in PPE | -48.7 Million | -103.59 Million | -308 Million | -59.55 Million | -66.86 Million | -65.31 Million |
Acquisitions | - | 109 Thousand | 87 Thousand | 10 Thousand | - | 77 Thousand |
Investment purchases | 92 Thousand | -326 Thousand | -1.24 Million | -71 Thousand | - | -720 Thousand |
Sales/Maturities of investments | - | - | - | - | - | 643 Thousand |
Other Investing Activities | -4.13 Million | 5.28 Million | -29.7 Million | -18.83 Million | 14.74 Million | -23.83 Million |
Financing Cash Flow | 29.34 Million | 33.26 Million | 18.31 Million | -560 Thousand | -15.74 Million | 26.8 Million |
Debt repayment | -55.64 Million | -56.04 Million | -238.41 Million | -52.96 Million | -614 Thousand | -615 Thousand |
Dividends payments | -26.9 Million | -26.85 Million | -213.34 Million | -53.39 Million | -53.32 Million | -53.24 Million |
Common Stock Repurchased | - | - | -11.46 Million | -1.2 Million | - | -10.26 Million |
Common Stock Issuance | 1.22 Million | 4.68 Million | 7.16 Million | 1.68 Million | 1.26 Million | 1.41 Million |
Other Financing Activities | -2.17 Million | 4.68 Million | 474.37 Million | 105.3 Million | 36.93 Million | 89.5 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -26.57 Million | 13.16 Million | 19.47 Million | 6.24 Million | -3.6 Million | -6.13 Million |
Cash at beginning of period | 43 Thousand | 55 Thousand | 74 Thousand | 53 Thousand | 77 Thousand | 72 Thousand |
Cash at end of period | 112 Thousand | 43 Thousand | 55 Thousand | 55 Thousand | 53 Thousand | 77 Thousand |
Capital Expenditure | -48.7 Million | -103.59 Million | -308 Million | -59.55 Million | -66.86 Million | -65.31 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 69 Thousand | -12 Thousand | -19 Thousand | 2000.00 | -24 Thousand | 5000.00 |
Free Cash Flow | -25.23 Million | -38.33 Million | 12.52 Million | 19.45 Million | 975 Thousand | -2.96 Million |
SVM
NEULANDLAB
600760
EBZT
DSAQ
002310